Nilanjana Majumdar, Ph.D.
Senior Scientist,Division Of Medicinal and Process Chemistry
Methodology development using asymmetric
catalysis and drug discovery.
Group Web Page
Click Here..
RESEARCH INTERESTS
1. Development of new synthetic strategies and drug discovery
2. Asymmetric catalysis & synthesis
3. Transition metal catalysis
4. Organocatalysis
5. Heterocyclic chemistry
The research interest in our group is focused on the methodology development especially asymmetric strategies and drug discovery. We are interested to synthesize medicinally important compounds. Therefore, the goal is to invent smart synthetic protocols for making compounds of high therapeutic importance. The techniques used are: transition metal catalysis, organocatalysis, C–H bond functionalization.
Asymmetric Synthesis of Natural Product-Inspired Novel Scaffolds for Drug Discovery
Nature has been the source of all our basic needs since ages, and, medicines for the treatment of a wide spectrum of diseases are no exception. Till date, therapeutic natural products are the main fundamental source of leads for the discovery of new drugs. Hence, it is highly rational to develop useful methodologies for the synthesis of compounds that are related to natural products of curative nature.
One efficient way to achieve this is via asymmetric catalysis. Our aim is to develop novel asymmetric methodologies to synthesize certain novel scaffolds (highlighted below) that are natural product inspired.